Impact of diverging AML/CFT regulations on EU-UK cross-border trades post-Brexit

Been thinking a lot lately about the increasing divergence in AML/CFT regimes between the EU and UK, especially as it pertains to financial institutions operating in both. It's not just the big banks, but the smaller fintechs too, dealing with cross-border payments and investments. On one hand, you have the EU pushing forward with its own AML authority and potentially more centralized oversight. On the other, the UK is refining its approach, often with different priorities and interpretations of risk.

This isn't a theoretical exercise; it directly impacts operational costs, compliance teams' workloads, and ultimately, the ease of doing business. Firms are essentially running two parallel compliance machines, each with nuanced requirements for customer due diligence (CDD), enhanced due diligence (EDD), and suspicious activity reporting (SARs). Are others seeing this as a significant drag on efficiency? How are you guys navigating the increased complexity around data sharing, beneficial ownership identification, and regulatory reporting when dealing with clients that bridge both jurisdictions? Seems like a growing headache that needs a pragmatic approach.